Progestin ‐primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing IVF/ICSI: a prospective randomized controlled trial
Conclusion(s)CC is an effective adjuvant to alleviate pituitary suppression in the PPOS protocol; however, it has no impact on clinical outcomes.This article is protected by copyright. All rights reserved.
Source: Clinical Endocrinology - Category: Endocrinology Authors: Yali Liu, Qiuju Chen, Sha Yu, Yun Wang, Wen He, Hannah Ya ‐Ning Chang, Bian Wang, Hongyuan Gao, Hui Long, Li Wang, Qifeng Lyu, Ai Ai, Yanping Kuang Tags: Original Article Source Type: research
More News: Clomid | Endocrinology | Hormones | ICSI (Intracytoplasmic Sperm Injection) | Infertility | Medroxyprogesterone | Men | Menopause | Ovaries | Pregnancy | Reproduction Medicine | Study | Women